Full Text View
Tabular View
Study Results
Related Studies
Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects
This study has been completed.
Study NCT01162122   Information provided by Novartis

First Received on July 13, 2010.   Last Updated on June 16, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Sponsors listed in this trial